Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), today announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems along with BR.io, a cloud-based instrument connectivity, ...

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX ™ Opus 96 Dx System and the CFX ™ Opus 384 Dx System, ...

The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing. Bio-Rad Laboratories, Inc.

The CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems represent the next generation of the company’s CFX Real-Time PCR Systems that are used in research and genomic testing as well as in pathogen ...

Bio-Rad’s CFX Opus Deepwell Real-Time PCR Detection System is designed to support researchers in developing nucleic acid detection assays. Bio-Rad Laboratories’s new CFX Opus Deepwell Real-Time ...

The Bio-Rad CFX Opus qPCR, equipped with a 96-well thermal block, is capable of detecting fluorescent signals across up to five channels. This ensures exceptional thermal uniformity and precise ...

The CFX Opus 96 Dx System and the CFX Opus 384 Dx System are the latest additions to Bio-Rad’s portfolio of real-time PCR instruments. The systems offer quantification to improve assay development, ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Real-Time PCR Detection System to support ...

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support researchers in ...

The CFX Opus Deepwell System has been added to the Bio-Rad™ portfolio of CFX Opus Real-Time PCR instruments. With a 96-well block, the CFX Opus Deepwell System was designed to offer quantification to ...